Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Enterprise Value (2016 - 2025)

Avanos Medical's Enterprise Value history spans 12 years, with the latest figure at -$89.0 million for Q3 2024.

  • For Q3 2024, Enterprise Value rose 16.9% year-over-year to -$89.0 million; the TTM value through Sep 2024 reached -$89.0 million, up 16.9%, while the annual FY2023 figure was -$87.7 million, 31.32% up from the prior year.
  • Enterprise Value for Q3 2024 was -$89.0 million at Avanos Medical, up from -$92.2 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$75.8 million in Q1 2024 and bottomed at -$187.7 million in Q1 2020.
  • The 5-year median for Enterprise Value is -$104.3 million (2022), against an average of -$114.0 million.
  • The largest annual shift saw Enterprise Value skyrocketed 46.67% in 2021 before it decreased 19.63% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$111.5 million in 2020, then fell by 6.28% to -$118.5 million in 2021, then dropped by 7.76% to -$127.7 million in 2022, then soared by 31.32% to -$87.7 million in 2023, then fell by 1.48% to -$89.0 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Enterprise Value are -$89.0 million (Q3 2024), -$92.2 million (Q2 2024), and -$75.8 million (Q1 2024).